QUOTE AND NEWS
TheStreet.com  Mar 18  Comment 
NEW YORK (TheStreet) -- Shares of Akorn are up 10.31% to $48.36 in afternoon trading today after the company filed its 2014 annual report after the closing bell yesterday after requesting an extension. It restated results for the second...
Benzinga  Mar 13  Comment 
Akorn, Inc. (NASDAQ: AKRX) gained more than 6 percent to $44.04 in the extended session Friday. The shares are off about 17 percent since posting quarterly results earlier this week. Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) picked up more...
Benzinga  Mar 11  Comment 
Express Inc. (NYSE: EXPR) gained 7.36% to $16.05 in pre-market trading after the company reported better-than-expected financial results for the fourth quarter. American Realty Capital Properties, Inc.(NASDAQ: ARCP) shares rose 6.74% to $9.96...
Benzinga  Mar 11  Comment 
Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced several generic product launches that build on Akorn's commitment to serve the company's specialty generic customers and patients. Adenosine Injection....
TheStreet.com  Mar 10  Comment 
NEW YORK (TheStreet) -- Shares of Akorn are down 14.31% to $44.42 today as the company reaffirmed its 2015 guidance issued on February 26, calling for revenue of between $960 million and $980 million, and adjusted diluted earnings per share of...
Forbes  Mar 4  Comment 
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.  So let's look at two noteworthy recent insider buys.
MarketWatch  Mar 4  Comment 
Specialty drugs company Akorn Inc. said Wednesday it has adopted a new policy of using its products only to promote human health and wellness, and will no longer supply midazolam and hydromorphone hydrochloride to prisons to be used in executions...





You may also be interested in articles related to Akorn (AKRX):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki